Impact Factor
3.04
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.02
469 total citations
h5-index
28
h5 depth signal
Cited share
44.0%
107 of 243
Total citations
469
Citation footprint
Metric signal
3.19
External metric anchor
Self-citation
4.3%
20 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
971
China
78
United Kingdom
70
Ukraine
51
Canada
50
Citing Fields of Research
Oncology
407
Breast Cancer
323
Liver & Colon Cancer
261
Cancer & Development
144
Genetics & Genomics
116
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
4,265
Articles tracked across the journal lifetime
Indexed publication set
243
107 cited publications
Last 12 months
74
6.2 publications/month
Open access share
21.6%
16 OA publications in the last year
Leading citing country
United States
971 citing publications
Leading citing field
Oncology
407 citing publications
Latest tracked publication
16 October 2026
10 recent records available
Coverage & Indexing History
v1n1, June 2008-
v1n1, June 2008-
Research Focus & Classification
Indexed Subjects
Oncology
Breast Cancer
Liver & Colon Cancer
Lung Cancer
Inflammatory Bowel Diseases & Infections
Issuing & Sponsoring Bodies
Contributor
American Association for Cancer Research
Broad Categories
Neoplasms
Liver & Colon Cancer
Oncology
Genetics & Genomics
Digestive Disorders
Endocrine Therapy
Breast Cancer
MeSH Descriptors
Neoplasms
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1158/1940-6207.capr-26-0174
Open DOI
Elucidating the Contexts That Enable or Constrain Normalization of Guideline-Based LDCT Lung Cancer Screening Processes in U.S. Primary Care
Routine primary care encounters offer a major opportunity to reach a large population of individuals eligible for lung cancer screening (LCS) in the U.S., potentially representing up to one-third of all primary care visits each year. Thi...
02
DOI 10.1158/1940-6207.capr-26-0170
Open DOI
SGLT2-mediated glucose uptake defines early metabolic reprogramming in lung adenocarcinoma
The metabolic reprogramming taking place during early lung adenocarcinoma (LUAD) progression remain poorly understood. While early-stage LUAD frequently demonstrates low 18F-2-fluorodeoxyglucose (18FDG) uptake on positron emission tomogr...
03
DOI 10.1158/1940-6207.capr-26-0102
Open DOI
Long-term Endoscopic Surveillance in Hereditary Diffuse Gastric Cancer Syndrome
Hereditary diffuse gastric cancer (HDGC) syndrome arises from a germline variant in CDH1 and is characterized by a high risk of gastric signet-ring cell carcinoma (SRCC). Total gastrectomy is the most definitive strategy for cancer risk ...
04
DOI 10.1158/1940-6207.capr-26-0019
Open DOI
The Association Between Metabolic Syndrome and Lung Cancer: A Systematic Review and Meta-analyses
Lung cancer has a 29% survival rate, with nearly half detected at Stage 4. Survival increases to 65% with early-stage diagnosis, yet only 28.1% are diagnosed early. Cardiovascular and respiratory comorbidities coexist with LC and may aff...
05
DOI 10.1158/1940-6207.capr-26-0137
Open DOI
Occupation and Lymphoma Risk by Cell of Origin: A Nationwide Matched Case–Control Study in Thailand
Lymphoma constitutes a substantial and increasing burden of hematologic malignancy in Thailand and globally, while its etiology remains incompletely characterized. Occupational factors have been implicated in lymphomagenesis; however, ev...
06
DOI 10.1158/1940-6207.capr-26-0180
Open DOI
Active Surveillance for Atypical Ductal Hyperplasia: Are We Ready for Surgical De-escalation?
Atypical ductal hyperplasia (ADH) remains one of the few benign breast lesions for which surgical excision is routinely recommended because of the risk of underlying carcinoma, most commonly ductal carcinoma in situ (DCIS). However, incr...
07
DOI 10.1158/1940-6207.capr-26-0125
Open DOI
Assessing Levels of Evidence for Cancer Screening: A Focus on Testicular Self-examination
Testicular cancer is the most common malignancy among men 15 to 45 years of age, with 5-year relative survival exceeding 95% when all stages are combined. Early detection may reduce treatment intensity, preserve fertility, and protect qu...
08
DOI 10.1158/1940-6207.capr-26-0145
Open DOI
Molecular Cancer Signal Origin Minimizes Diagnostic Burden: Letter
09
DOI 10.1158/1940-6207.capr-19-10-hfl
Open DOI
Editors’ Selections from Relevant Scientific Publications
10
DOI 10.1158/1940-6207.capr-26-0159
Open DOI
Barriers to Diagnostic Colonoscopy after a Positive Stool-Based Screening Test: A Scoping Review
Noninvasive stool-based colorectal cancer screening [e.g., fecal immunochemical test (FIT), guaiac fecal occult blood test (gFOBT), and multitarget stool DNA test (mt-sDNA)] reduces colorectal cancer mortality only when a positive result...
Bibliographical & Catalog Notes
Title from cover.
Latest issue consulted: Vol. 1, no. 4 (Sept. 2008).
Print issues ceased with v. 13, no. 12 (Dec. 2020).
Also issued online.